XENE
Xenon Pharmaceuticals Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website xenon-pharma.com
- Employees(FY) 203
- ISIN CA98420N1050
Performance
-6.33%
1W
-4.07%
1M
-18.63%
3M
+38.68%
6M
-13.59%
YTD
-3.66%
1Y
Profile
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, a Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epileptic encephalopathy; and XEN1101, a Kv7 potassium channel opener, which is in Phase II clinical trial for the treatment of epilepsy and other neurological disorders. The company's product candidates also comprise NBI-921352, a selective Nav1.6 sodium channel inhibitor that is in Phase II clinical trials for the treatment of SCN8A developmental and epileptic encephalopathy, and other indications, including adult focal epilepsy. It has a license and collaboration agreement with the Neurocrine Biosciences, Inc. to develop treatments for epilepsy. The company was incorporated in 1996 and is headquartered in Burnaby, Canada.
Investment Analysis Report: XENE
Overview
XENE is a pharmaceutical company operating in the Health Technology sector, specifically in the Pharmaceuticals: Major industry. The company has a market capitalization of $3.61 billion. In this report, we will conduct a comprehensive analysis of XENE's financial statements to evaluate its valuation, fin...
Technical Analysis of XENE 2024-05-10
Overview:
In analyzing the technical indicators for XENE over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key aspects, we aim to offer valuable insights and predictions for the upcoming days.
Trend Analysis:
...Recent News & Updates
- 2024-03-05 03:01
- 2024-03-02 08:37
- 2024-03-01 08:35
- 2024-02-29 19:35
- 2024-02-29 16:34
- 2024-02-29 16:13
Xenon Pharmaceuticals: Q4 Earnings Snapshot(Associated Press Finance)
- 2024-02-29 16:01
- 2024-02-29 03:01
- 2024-02-22 16:01
- 2024-02-22 03:01
- 2024-02-21 22:08
- 2024-02-07 05:04
- 2024-01-23 08:36
- 2024-01-19 09:55
- 2024-01-18 20:55
- 2024-01-08 08:00
- 2024-01-07 19:00
- 2024-01-03 08:30
- 2024-01-02 19:30
- 2023-12-05 00:31
5 Most Promising Stocks to Buy According to Hedge Funds(insidermonkey)
- 2023-12-04 16:16
- 2023-12-04 06:30
- 2023-12-04 03:16
- 2023-12-02 12:01
- 2023-12-01 23:01
- 2023-11-29 22:51
- 2023-11-29 16:03
Xenon Pharmaceuticals Announces Proposed Public Offering(GlobeNewswire)
- 2023-11-29 09:51
- 2023-11-29 03:03
Xenon Pharmaceuticals Announces Proposed Public Offering(globenewswire)
- 2023-11-28 11:17